Toxicity of anticancer agents mediated by electroporation in vitro

Electroporation is a physical event that temporarily reduces cell membrane barrier properties. Diminished membrane barrier properties are achieved by exposing cells to pulsed electric fields. When a cell has been treated with electric fields it is possible for extracellular agents to gain access to the cell interior. This process has been used in vivo to increase the uptake of chemotherapeutic agents by tumor cells which results in dramatically higher response rates than when drug is used alone. This type of treatment is called electrochemotherapy (ECT); bleomycin is most often used as the drug for this type of treatment. It was hypothesized that electroporation could be used to augment the cytotoxicity of other anticancer agents. Therefore, this study was performed in order to screen 44 different combinations of drug and cell type in vitro to identify drugs that may have higher cytotoxicity when combined with electroporation. Results from seven cell types indicate that the IC50 of bleomycin can be reduced by a factor of 100-5000 when electroporation is used to facilitate internalization. The IC50 values of cisplatin and carboplatin could be reduced by factors ranging from 3 to 13 in six different cell lines as a result of electroporation. These IC50 reductions in multiple cell lines suggest that cisplatin and carboplatin may be effective in vivo as part of ECT treatment.

[1]  L. Mir,et al.  Electrochemotherapy: variable anti-tumor effect on different tumor models , 1994 .

[2]  L. Mir,et al.  Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. , 1994, Biochimica et biophysica acta.

[3]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[4]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[5]  D. Miklavčič,et al.  Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin. , 1998, Anticancer research.

[6]  P. Seglen,et al.  Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. , 1986, European journal of cancer & clinical oncology.

[7]  D. Miklavčič,et al.  Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients , 1995 .

[8]  J. Teissié,et al.  Direct experimental evidence of the vectorial character of the interaction between electric pulses and cells in cell electrofusion. , 1984, Biochimica et Biophysica Acta.

[9]  M. Jaroszeski,et al.  Clinical applications of electrochemotherapy. , 1999, Advanced drug delivery reviews.

[10]  R. Kanamaru,et al.  Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation. , 1996, The Tohoku journal of experimental medicine.

[11]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[12]  L. Mir,et al.  Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. , 1988, Experimental cell research.

[13]  L. Salford,et al.  DYNAMIC GAMMA CAMERA STUDIES OF 111IN-BLEOMYCIN COMPLEX IN NORMAL AND GLIOMA BEARING RATS AFTER IN VIVO ELECTROPERMEABILIZATION USING EXPONENTIAL HIGH -VOLTAGE PULSES , 1998 .

[14]  D Miklavcic,et al.  Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.

[15]  D. Miklavčič,et al.  Improved therapeutic effect of electro chemotherapy with cisplatin by intratumoral drug administration and changing of electrode orientation for electropermeabilization on EAT tumor model in mice , 1995 .

[16]  J. Teissié.  Time Course of Electropermeabilization , 1992 .

[17]  J. Gehl,et al.  Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs , 1998, Anti-cancer drugs.

[18]  M. Hirata,et al.  Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma. , 1997, Gynecologic oncology.

[19]  P. Papenhausen,et al.  Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary , 1997, In Vitro Cellular & Developmental Biology - Animal.

[20]  D. Chang,et al.  High-efficiency gene transfection by in situ electroporation of cultured cells. , 1991, Biochimica et biophysica acta.

[21]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. , 1998, European journal of cancer.

[22]  M. Jaroszeski,et al.  Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem , 1995 .

[23]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[24]  M. Okino,et al.  Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.

[25]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[26]  D. Miklavčič,et al.  Intrinsic Sensitivity of Tumor Cells to Bleomycin as an Indicator of Tumor Response to Electrochemotherapy , 1998, Japanese journal of cancer research : Gann.

[27]  L. Mir,et al.  Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.

[28]  H. Itoh,et al.  Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope. , 1988, Biophysical journal.

[29]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.